IEQ Capital’s Pacific Biosciences PACB Stock Holding History

IEQ Capital’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-123,782	Closed	-$208K	–	2168
2026 Q2	$208K	Buy	123,782 +11,084	+10%	+$16.1K	﹤0.01%	1823
2026 Q1	$149K	Buy	+112,698	New	+$202K	﹤0.01%	1750
2025 Q4	–	Sell	-11,154	Closed	-$14.3K	–	1962
2025 Q3	$14.3K	Hold	11,154	–	–	﹤0.01%	1827
2025 Q2	$13.8K	Sell	11,154 -270	-2%	-$312	﹤0.01%	1801
2025 Q1	$13.5K	Hold	11,424	–	–	﹤0.01%	1594
2024 Q4	$20.9K	Hold	11,424	–	–	﹤0.01%	1319
2024 Q3	$19.4K	Hold	11,424	–	–	﹤0.01%	1149
2024 Q2	$15.7K	Sell	11,424 -47	-0.4%	-$95	﹤0.01%	997
2024 Q1	$43K	Buy	11,471 +47	+0.4%	+$275	﹤0.01%	952
2023 Q4	$112K	Hold	11,424	–	–	﹤0.01%	881
2023 Q3	$95.4K	Hold	11,424	–	–	﹤0.01%	894
2023 Q2	$152K	Hold	11,424	–	–	﹤0.01%	823
2023 Q1	$132K	Hold	11,424	–	–	﹤0.01%	841
2022 Q4	$93.4K	Hold	11,424	–	–	﹤0.01%	773
2022 Q3	$66K	Hold	11,424	–	–	﹤0.01%	816
2022 Q2	$50K	Hold	11,424	–	–	﹤0.01%	784
2022 Q1	$104K	Buy	+11,424	New	+$132K	﹤0.01%	790

Other funds holding PACB

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Nikko Asset Management Americas New York $8.04B AUM 33.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return

IEQ Capital's PACB Position: Q3 2026 in Review

IEQ Capital sold out of Pacific Biosciences (PACB) in Q3 2026, closing a stake of 123,782 shares — an estimated $208K sold.

IEQ Capital first reported a position in PACB in Q1 2022 and held it in 17 quarters. The position peaked at $208K in Q2 2026. 146 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

IEQ Capital reported no remaining Pacific Biosciences position as of Q3 2026 after selling out during the quarter.
IEQ Capital sold 123,782 Pacific Biosciences shares in Q3 2026, an estimated $208K.
IEQ Capital first reported a position in Pacific Biosciences in Q1 2022 and held it in 17 quarters.
IEQ Capital's Pacific Biosciences position peaked at $208K in Q2 2026.
146 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.